The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
US medical drug shortages reach record high
Apr 15, 2024
Americans are facing more shortages of the drugs they need for medical care than ever before, a national pharmacy database shows.
Eli Lilly reports temporary shortage of Humalog and Insulin Lispro Injection
Mar 25, 2024
Products are expected to be out of stock at wholesalers and pharmacies through the beginning of April.
Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
Biden administration calls for greater access to overdose antidote
Mar 13, 2024
The need for naloxone is great: Overdose deaths spiked 30% between 2019 and 2020 and another 15% between 2020 and 2021.
Cyberattack stalls prescription dispensing at UnitedHealth
Feb 27, 2024
This latest cyberattack underscores the vulnerability of healthcare data, particularly the privacy of patients’ personal information.
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.
FDA approves Aurlumyn for severe frostbite
Feb 15, 2024
The newly approved medication lowers the need for amputation of fingers or toes.